Ayurveda the
divine science of life
Botany: Kan.
t.
aka¯ri
is a highly branched perennial
herb, with an irregularly shaped stem that is
somewhat
woody at the base, covered in whitish hairs,
with
shining yellowish prickles that are up to 1.3
cm long.
The leaves are up 5–10 cm in length and
between 2.5
and 6 cm wide, ovate to elliptic, deeply
lobed, covered
in whitish hairs and prickles along the
midrib and
veins. The purple or blue flowers are borne
in axillary
cymes, giving rise to small globose berries
that are yellowish
white, with green veins, containing small
yellowish
brown seeds. Kan.
t.
aka¯ri
is found throughout
tropical India
and Southeast Asia (Kirtikar & Basu
1935).
Part used:Whole plant, root.
Dravygun. a:
● Rasa: kat.u, tikta
● Vipa¯ka: kat.u
● Vı¯rya: us.n.
a, ru¯ks.
a
● Karma: dı ¯panapa¯cana, anulomana, kr . mighna,
jvaraghna, chedana, ka¯sahara, sva¯sahara,
mu¯travirecana, a´smaribhedana, hr . daya, a¯rtavajanana,
va¯takaphahara (Srikanthamurthy 2001, Warrier
et al 1996)
Constituents: The limited amount of chemical
research on Kan.
t.
aka¯ri
has yielded the steroidal
glycosides
carpesterol, indioside, -sitosterol, dioscin,
methyl protoprosapogenin A, methyl
protodioscin and
protodioscin. In addition researchers have
isolated the
sesquiterpene solavetivone, a novel
solafuranone,
scopoletin, esculin, esculetin, N-(p-transcoumaroyl)
tyramine, and N-trans-feruloyltyramine, as well as the
alkaloids solanine, solanidine, solasonine,
solamargine,
and solaurine (Chiang et al 1991, Gan et al
1993, Kapoor 1990, Syu et al 2001,
Yoganarasimhan
2000).
Medical research:
● Human
trials: Solanum xanthocarpum and
Solanum trilobatum were demonstrated to promote
a significant improvement in the ventilatory
function of asthmatic individuals, without
side
effects (Govindan et al 1999, 2004).
Toxicity: No data found.
Indications: Dyspepsia,
colic, flatulence, constipation,
haemorrhoids, intestinal parasites, fever,
catarrh, cough, bronchitis, pharyngitis,
asthma,
urolithiasis, oedema, skin diseases,
inflammatory joint
disease, sciatica, cardiovascular disease,
amenorrhoea,
dysmenorrhoea, epilepsy.
Contraindications: pittakopa.
Medicinal uses: Kan.
t.
aka¯ri
is a warming, stimulating
herb, with a dı¯panapa¯cana
activity that is useful
to correct digestion and remove catarrh,
commonly
used in the treatment of fever (jvara), digestive weakness
and respiratory conditions. For fever with
pain in
the chest Kan.
t.
aka¯ri
is decocted with Goks.ura, and
taken with red rice (Sharma 2002). In the
treatment of
cough the Cakradatta
recommends a decoction of
Kan.
t.
aka¯ri
and Harı¯takı¯, taken with honey and a
paste of Trikat.u
(Sharma 2002). Similarly, a
medicated
ghr.
ta prepared with the fresh juice of
Kan.
t.
aka¯ri
and powders of Ra¯sna¯, Bala¯, Goks.ura
and Trikat.u is used to treat the different types of
cough as well as hoarseness (Sharma 2002). In
the
treatment of colic Kan.
t.
aka¯ri
is decocted with Bala¯,
Punarnava¯, Goks.ura, and Br. hatı¯, taken with Hin.gu
and rock salt (Sharma 2002). In the treatment
of
haemorrhoids Kan.
t.
aka¯ri
is prepared as a medicated
Kan.
t.
aka¯ri, ‘thorny’
BOTANICAL NAME: Solanum xanthocarpum, S. surattense, Solanaceae
OTHER NAMES: Vya¯ghrı¯, ‘tigress’ (S); Birhatta (H); Kandangattiri,
Papparapalli (T); Yellowberried Nightshade
226 PART 2: A¯ yurvedic materia medica
ghr.
ta called Simhyamr.
ta ghr. ta, prepared by
decocting
it along with Gud.u¯cı¯, and a smaller proportion of
Citraka, Triphala, Pu¯tika¯ bark, Indrayava,
Gambha¯ri
and Vid.
an.ga
(Sharma 2002). As a ‘simple’
(remedy), a decoction of Kan.
t.
aka¯ri
taken with honey
is stated to be effective in all forms of
dysuria and
urolithiasis (Sharma 2002). In the treatment
of parasites
Kan.
t.
aka¯ri
is used with antihelminthic herbs
such
as Vid.
an.ga, and purgatives such as Trivr.
t.
Dosage:
● Cu¯rn.
a: 3–5 g b.i.d.–t.i.d.
● Kva¯tha: 30–90 mL b.i.d.–t.i.d.
REFERENCES
Chiang HC, Tseng TH, Wang CJ et al 1991
Experimental antitumor
agents from Solanum indicum L. AntiCancer
Research
11(5):1911–1917
Gan KH, Lin CN, Won SJ 1993 Cytotoxic
principles and their derivatives
of Formosan Solanum plants. Journal of
Natural Products
56(1):15–21
Govindan S, Viswanathan S, Vijayasekaran V,
Alagappan R 1999
A pilot study on the clinical efficacy of
Solanum xanthocarpum
and Solanum trilobatum in bronchial asthma.
Journal of
Ethnopharmacology 66(2):205–210
Govindan S, Viswanathan S, Vijayasekaran V,
Alagappan R 2004
Further studies on the clinical efficacy of
Solanum xanthocarpum
and Solanum trilobatum in bronchial asthma.
Phytotherapy Research 18(10):805–809
Kapoor LD 1990 CRC Handbook of Ayurvedic
medicinal plants. CRC
Press, Boca
Raton, p 305
Kirtikar KR, Basu BD 1935 Indian medicinal
plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1759–1760
Nadkarni KM 1954 The Indian materia medica,
with Ayurvedic,
Unani and home remedies, revised and enlarged
by A.K.
Nadkarni. Popular Prakashan PVP, Bombay
Sharma PV 2002 Cakradatta. Sanskrit text with
English translation.
Chaukhamba, Varanasi, p 4, 88, 155, 163, 257, 311
Srikanthamurthy KR 1994 Va¯gbhat.
a’s As.t.
a¯ñga Hr. dayam, vol 1.
Krishnadas Academy,
Varanasi
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of
Bha¯vami´sra, vol 1.
Krishnadas Academy,
Varanasi, p 233
Syu WJ, Don MJ, Lee GH, Sun CM 2001 Cytotoxic
and novel compounds
from Solanum indicum. Journal of Natural Products
64(9):1232–1233
Warrier PK, Nambiar VPK, Ramankutty C (eds)
1996 Indian medicinal
plants: a compendium of 500 species, vol 5.
Orient
Longman, Hyderabad, p 164
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2:
Tamil
Nadu. Self-published, Bangalore, p 505
Kapikacchu¯
, ‘monkey itcher’ 227
Botany: Kapikacchu¯ is a climbing annual with slender,
pubescent branches. The leaves are
trifoliate,
attached by a long petiole up to 12 cm long,
the
leaflets ovate, elliptic to rhomboid ovate,
7–15 cm
long, the terminal leaflet slightly larger,
the leaf surface
pubescent above and densely covered in
silverygrey
hairs below, margin entire. The purple
flowers are
borne in elongated racemes of up to 30
flowers, giving
rise to curved pods with longitudinal ribs,
covered in
brown or grey bristles, 5–7.5 cm long, each
containing
four to six black ovoid seeds. Kapikacchu¯
is found
throughout India,
Africa and Southeast Asia (Kirtikar
& Basu 1935, Warrier et al 1995).
Part used: Seeds.
Dravygun. a:
● Rasa: amla, tikta, ka´sa¯ya, madhura
● Vipa¯ka: guru
● Vı¯rya: us.n.
a
● Karma: medhya, balya, vajı ¯karan. a, va¯tapittahara
(Srikanthamurthy 2001, Warrier et al 1995).
Constituents: The most prominent constituent in
Kapikacchu¯
is L-dopa
(3,4-dihydroxy-L-phenylalanine
or 3-hydroxy-L-tyrosine), present in
concentrations
that range from a low of 1.81% for an
accession named
M. pruriens var. utilis grown in the USA,
to a high of
7.64% for an accession named M. pruriens var.
cochinchinensis grown in Bénin. It appears that
L-dopa synthesis in the various cultivars is
higher in
plants grown at low latitudes, near the
equator.
Researchers have also identified a number of
hallucinogenic
indoles such as bufotenine, N,N-dimethyltryptamine
and other tryptamines including serotonin,
the latter of which is found in high
concentrations in
the bristles on the seed pods, which can
cause profound
skin irritation similar to a Nettle rash
(hence the name
‘itcher of monkeys’). Other constituents
include
physostigmine, cyanogenic glycosides, trypsin
and
amylase inhibitors, tannins, lectins, and
phytic acid.
Several alkaloids have also been identified,
including
nicotine, mucunine, mucunadine, prurienine,
prurienidine, prurieninine, as well as an oil
composed
of stearic, palmatic, myristic, arachidic,
oleic, and
linoleic acids, phytosterols and lecithin
(Burgos et al
2002, Kapoor 1990, St-Laurent et al 2002,
Szabo &
Tabbet 2002, Yoganarasimhan 2000).
Medical research:
● In
vitro: antioxidant (Tripathi &
Upadhyay 2002)
● In
vivo: antidiabetic (Rathi et al 2002),
antivenom
(Aguiyi et al 2001)
● Human
trials: Used after 28 days of pañca
karma
therapy, a formula comprising Mucuna
pruriens, Hyoscyamus reticulatus, Withania somnifera
and Sida cordifolia, decocted in cow’s milk,
promoted a significant improvement in
symptoms
of Parkinson’s disease (Nagashayana et al
2000).
An extract of Mucuna pruriens was found to promote
statistically significant reductions in Hoehn
and Yahr Stage scores and the Unified
Parkinson’s
Disease Rating Scale (UPDRS) scores in
patients
with Parkinson’s disease (Manyam et al 1995).
Compared with standard L-dopa/carbidopa, 30 g
of
Mucuna pruriens extract given to patients suffering
from Parkinson’s disease led to a more rapid
onset of action and longer effect without a
concomitant
increase in dyskinesia (Katzenschlager
et al 2004).
Kapikacchu¯, ‘monkey itcher’
BOTANICAL NAME: Mucuna pruriens, Papilionaceae (Fabaceae)
OTHER NAMES:A¯tmagupta¯,
‘concealed self’ (S); Goncha,
Kevancha, Khujani (H);
Punaikkali (T); Cowitch, Cowhage (E)
228 PART 2: A¯ yurvedic materia medica
Toxicity: A study examining the oral toxicity
of
Mucuna pruriens on albino rats for 30 days showed no
toxic effect up to a dose of 600 mg/kg
(Tripathi
& Upadhyay 2002). Kapikacchu¯
contains phytic acid,
which binds to minerals in the gut thereby
inhibiting
their absorption, as well as lectins, which
can promote
gastrointestinal upset and inflammation. Some
studies
have shown GI upset to be a minor side-effect
of
higher doses.
Indications: Weakness,
debility, consumption, wasting,
asthenia, infertility, frigidity, spasm,
tremor,
chorea, Parkisonson’s disease, dementia.
Contraindications: Pre-existing sensitivities to
legumes, inflammatory bowel disease and
irritable
bowel syndrome.
Medicinal uses: Kapikacchu¯ has long been valued in
A¯
yurveda as one of the most effective vajı¯karan.
a
dravyas, used in both men and women, but
specifically
male sexual dysfunction, such as erectile
dysfunction, premature ejaculation and sperm
pathologies. To this end Kapikacchu¯
is often combined
with botanicals such as Goks.ura
and A´svagandha¯
for
men, and with Goks.ura
and ´Sata¯varı¯
in the treatment
of frigidity and leucorrhea in women. As an
allpurpose
vajı¯karan.
a rasa¯yana the Bha¯vapraka¯´sa
recommends a formulation for a vat.
ı¯ (‘pill’) called
Va¯na¯rı¯
vat.ı¯, made by decocting one kud.ava
(approx.
192 g) of the seed-pods in one prastha
(approx. 768
mL) of cow’s milk until the milk becomes
thick. The
seeds are then removed from the pods and
pounded,
fried in ghr.
ta, and mixed with twice their weight
in
jaggery. The resultant preparation is then
rolled into
small pills and dosed at about 3–4 g, twice
daily
(Srikanthamurthy 2000). Kapikacchu¯
is also widely
used in the treatment of almost any va¯ta
disorder used
to strengthen the mind and body in
debilitated states,
used in combination with botanicals such as A´svagandha
¯, A¯malakı¯, Bra¯hmı¯ and Jat.
a¯ma¯msı¯. It is an
important remedy in many spasmodic
afflictions, both
topically and internally, including
paralysis, hemiplegia
and kampava¯ta (paralysis agitans). In the treatment
of Parkinson’s disease Kapikacchu¯
has shown
benefit in clinical trials, used singly or in
combination
with botanicals such as A´svagandha¯, Bala¯, and
Pa¯rasikayava¯nı¯. Mixed with equal parts powders of
Arjuna
and Na¯gabala¯, Kapikacchu¯ seed powder is
fried in ghr.
ta and cooked with milk and sugar to make
Kakubha¯di
modaka, used in the treatment of cough,
bronchitis and consumption (Sharma 2002). As
a
member of the Fabaceae Kapikacchu¯
contains many
of the same constituents found in beans that
can promote
gastrointestinal distress, and thus measures
should be taken to include herbs with a pa¯cana
activity
in formulation, such as ´Su¯n.t.
hı¯. The seeds are traditionally
referred to as an antivenomous remedy against
scorpion sting and snakebite, which has been
validated
by modern research. The hairs scraped from
the pods
are traditionally used topically as an
irritant in fainting,
and internally as a decoction in the
treatment of
intestinal parasites.
Dosage:
● Cu¯rn.
a: freshly powdered dried seed, 3–10 g
b.i.d.–t.i.d.
● Tincture: crushed seeds, 1:4, 25% alcohol, 3–15 mL
REFERENCES
Aguiyi JC, Guerranti R, Pagani R, Marinello E
2001 Blood chemistry
of rats pretreated with Mucuna pruriens seed
aqueous
extract MP101UJ after Echis carinatus venom
challenge.
Phytotherapy Research 15(8):712–714
Burgos A, Matamoros
I, Toro E 2002 Evaluation of velvet bean
(Mucuna pruriens) meal and Enterolobium ciclocarpum
fruit
meal as replacements for soybean meal in
diets for dualpurpose
cows. In: Flores
M, Eilittä M, Myhrman R et al (eds)
Food and feed from Mucuna: current uses and
the way forward.
Cover Crops Internal Clearinghouse (CIDICCO),
Tegucigalpa, Honduras, p 228–237
Kapoor LD 1990 CRC handbook of Ayurvedic
medicinal plants.
CRC Press, Boca Raton, p 236
Katzenschlager R, Evans A, Manson A et al
2004 Mucuna pruriens
in Parkinson’s disease: a double blind
clinical and pharmacological
study. Journal of Neurology, Neurosurgery and
Psychiatry 75(12):1672–1677
Kirtikar KR, Basu BD 1935 Indian medicinal
plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 778–780
Manyam
BV 1995
An alternative medicine treatment for
Parkinson’s disease: results of a multicenter
clinical trial.
HP–200 in Parkinson’s Disease Study Group.
Journal of
Alternative and Complementary Medicine
1(3):249–255
Nadkarni KM 1954 The Indian materia medica,
with Ayurvedic,
Unani and home remedies, revised and enlarged
by A.K.
Nadkarni. Popular Prakashan PVP, Bombay
Nagashayana N, Sankarankutty P, Nampoothiri
MR et al 2000
Association of L-DOPA with recovery following
Ayurveda medication
in Parkinson’s disease. Journal of the
Neurological
Sciences 176(2):124–127
Rathi SS, Grover JK, Vats V 2002 The effect
of Momordica charantia
and Mucuna pruriens in experimental diabetes
and their
effect on key metabolic enzymes involved in
carbohydrate
metabolism. Phytotherapy Research
16(3):236–243
Kapikacchu¯
, ‘monkey itcher’ 229
Sharma PV 2002 Cakradatta: Sanskrit text with
English translation.
Chaukhamba, Varanasi, p 134
Srikanthamurthy KR 2000 Bha¯vapraka¯´sa of
Bha-vami´sra, vol 2.
Krishnadas Academy,
Varanasi, p 834
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of
Bha¯vami´sra, vol 1.
Krishnadas Academy,
Varanasi, p 248
St-Laurent L, Livesey J, Arnason JT, Bruneau
A 2002 Variation in
L-dopa concentration in accessions of Mucuna
pruriens (L.)
DC. and in Mucuna brachycarpa Rech. In: Flores M, Eilittä M,
Myhrman R et al (eds) Food and feed from
Mucuna: current
uses and the way forward. Cover Crops
Internal
Clearinghouse (CIDICCO), Tegucigalpa, Honduras,
p 352–374
Szabo NJ, Tebbett IR 2002 The chemistry and toxicity
of Mucuna
species. In: Flores
M, Eilittä M, Myhrman R et al (eds) Food and
feed from Mucuna: current uses and the way
forward. Cover
Crops Internal Clearinghouse (CIDICCO), Tegucigalpa,
Honduras, p 120–141
Tripathi YB, Upadhyay AK 2002 Effect of the
alcohol extract of the
seeds of Mucuna pruriens on free radicals and
oxidative stress
in albino rats. Phytotherapy Research
16(6):534–538
Warrier PK, Nambiar VPK, Ramankutty C (eds)
1995 Indian
medicinal plants: a compendium of 500
species, vol 4. Orient
Longman, Hyderabad, p 68
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2:
Tamil
Nadu. Self-published, Bangalore, p 366
230 PART 2: A¯ yurvedic materia medica
Botany: Kat.uka
is a small pubescent perennial herb
that spreads by elongated creeping rhizomes,
about the
thickness of the little finger. The leaves
are basal, leathery,
spatulate in shape with serrated margins, the
tip
rounded, about 5–10 cm in length. The white
or bluish
flowers are borne on stems as a terminal
spicate raceme,
longer than the leaves and for the most part
naked. The
fruits are ovoid capsules. Kat.uka
is native to alpine
regions in the Himalayas, from Kashmir to Sikkim,
2700 to 4500 m in elevation. Unregulated
overharvesting
has made Kat.uka
a threatened species in Nepal and
is listed in CITES Appendix II (Kirtikar
& Basu 1935,
MOPE 2001, Warrier et al 1995).
Part used: Rhizome. Two varieties are described:
a white variety, which is intensely bitter,
and a black
variety, which is less so (Kirtikar &
Basu 1935).
Dravygun. a:
● Rasa: tikta, kat.u
● Vipa¯ka: kat.u
● Vı¯rya: ´sita, ru¯ks.
a
● Karma: dı¯panapa¯cana, bhedana, kr . mighna,
jvaraghna, ka¯sahara, sva¯sahara,
raktaprasa¯dana,
kus.t.
haghna, pittakaphahara (Srikanthamurthy
2001, Warrier et al 1995).
Constituents: The best
studied constituents of
Kat.uka
are its glycosides, such as
picrorhizin, which is
stated to be its bitter-tasting principle,
and specifically,
a glycosidal fraction referred to as
picroliv, standardised
to contain a mixture of at least 60%
kutkoside and
the iridoid glycoside picroside I. Since the
isolation of
picroliv, however, a number of related
iridoid glycosides
have been described, including picrosides II,
III
and IV, pikuroside and 6-feruloyl catalpol.
Other constituents
isolated from Kat.uka
root include a group of
phenylethanoid glycosides called scrosides
A–C, the
phenol glycoside androsin, the catechol
apocynin, nine
cucurbitacin glycosides, D-mannitol, kutkiol,
kutkisterol,
and glucosidovanilloyl glucose (Duke 2002,
Jia
et al 1999, Li et al 1998, Kapoor 1990, Smit
et al
2000, Stuppner & Wagner 1989).
Medical research:
● In
vitro: anti-HBsAg (Mehrotra et al 1990),
antioxidant
(Chander et al 1992), anti-inflammatory
(Engels et al 1992).
● In
vivo: hepatoprotective (Chander et al
1998,
Dwivedi et al 1992, Jeena et al 1999, Mittal
1998,
Rajeshkumar & Kuttan 2000, Santra et al
1998,
Saraswat et al 1997, 1999, Singh et al 1992),
immunostimulant (Puri et al 1992, Sharma et
al
1994), anti-anaphylaxis (Baruah et al 1998,
Dorsch et al 1991), antimicrobial (Mittal
1998;
Chander et al 1998), antioxidant (Gaddipati
et al
1999, Rastogi et al 2001, Singh et al 2000),
cardioprotective
(Senthil Kumar et al 2001), antidiabetic
(Joy & Kuttan 1999), antitumour (Joy et
al
2000, Rajeshkumar & Kuttan 2001).
● Human
trials: Kat.uka
root powder promoted
significant improvements in serum bilirubin,
SGOT
and SGPT compared to placebo in patients
diagnosed
with acute viral hepatitis (HBsAg negative)
(Vaidya et al 1996).
Toxicity: The potential toxicity of Kat.uka
has not
been well studied, but from a survey of the
literature,
both ancient and modern, Kat.uka
appears to be relatively
non-toxic. Duke (2002) reports that the
curcubitans
may be responsible for ‘ . . . diarrhea, gas
and
griping’, and have an oral LD50 of 10.9 mg/kg
in mice.
Kat.uka, ‘pungent’
BOTANICAL NAME: Picrorrhiza kurroa, Scrophulariaceae
OTHER NAMES: Kutki (H); Katukurogani (T); Picrorrhiza (E); Hu huang
lian (C)
Kat.uka, ‘pungent’ 231
Indications: Bilious dyspepsia, hepatic torpor, constipation,
fever, cough, bronchitis, asthma, allergies,
burning sensation, inflammatory skin
conditions,
infection, jaundice, hepatitis, cirrhosis,
oedema,
inflammatory joint disease, cancer.
Contraindications: In large doses Kat.uka may act as
a purgative, and should be avoided during
pregnancy.
In addition, the exceptionally cooling and
drying
nature of Kat.uka
make it contraindicated in
va¯takopa, without utilising proper adjuncts in
formulation.
Mills & Bone (2000) state that Kat.uka
acts as
a potent immunostimulant, and thus may be
contraindicated
in autoimmune disease and immune
dysregulation.
Medicinal uses: Kat.uka is an archetypal bitter herb
in A¯ yurvedic medicine, with a linear
relationship
between its intensely bitter taste (tikta
rasa) and its
cold and dry energies (´sita
ru¯ks.
a vı¯rya). Thus
Kat.uka
is indicated primarily in pitta
(hot) and
kapha
(wet) conditions, and should be
used only in
small doses or for short periods of time in va¯ttika
states. Why exactly Kat.uka
is called ‘pungent’ is not
entirely clear, as kat.u
is at best an anu
rasa, or secondary
taste – in some texts Kat.uka
is classified as
having an us.n.
a vı¯rya, and this may explain the discrepancy.
As a bitter herb, Kat.uka
is obviously important
in liver and spleen dysfunction, used in
simple
states of hepatic torpor and bilious
dyspepsia, as well
as in hepatosplenomegaly, drug-induced liver
injury,
viral hepatitis, jaundice, cirrhosis and
liver flukes,
usually in combination with aromatic dı¯panapa¯cana
herbs to reduce any possible griping. In the
treatment
of viral hepatitis Kat.uka
may be of benefit when combined
with other antiviral botanicals such as
Bhu¯nimba, Wu wei zi (Schizandra chinensis), St John’s
Wort (Hypericum perforatum) and Osha (Ligusticum
porteri). In the treatment of jaundice and other liver
disorders, the Cakradatta
recommends a decoction of
Kat.uka
with equal parts Triphala, Gud.u¯cı¯, Vaca¯,
Kira¯tatikta¯
and Nimba, taken with honey
(Sharma 2002). Kat.uka
is also used more generally
in a variety of digestive disorders, such as
constipation,
in which it is used in small amounts combined
with dı¯panapa¯cana remedies such as Triphala,
Hingvatsak
and saindhava. In the treatment of malabsorption
(grahan. ı¯), with bloody diarrhoea and
haemorrhoids, the Cakradatta
recommends a cu¯rn.
a
called Na¯gara¯dya cu¯rn.
a composed of equal parts
Kus.
t.
ha, ´Su¯n.t.
hı¯, purified Ativis.a¯, Mustaka,
Dha¯taki, Rasa¯ñjana, Kut.aja, Bilva and Pa¯t.ha¯,
mixed with honey and taken with peya
(rice water)
(Sharma 2002). In the treatment of udara
(intestinal
parasites) and secondary anaemia the Cakradatta
recommends Kat.uka
decocted with equal parts
Punarnava¯, Nimba, Pat.
ola, ´Su¯n.t.
hı¯, Gud.u¯cı¯,
Devada¯ru
and Harı¯takı¯. This remedy is also stated to
be useful in cough and dyspnoea (Sharma
2002). As a
cooling, anti-inflammatory remedy, Kat.uka
is important
in pittakopa conditions, with symptoms of heat
and burning, as well as in inflammatory and
infectious
skin conditions. In the treatment of paittika
jvara
(fever) for example, the Cakradatta
recommends
that Kat.uka be decocted with equal parts
Indrayava, Kat.phala, Mustaka, and Pa¯t.ha¯
(Sharma 2002). In the treatment of
inflammatory
joint diseases such as gout, particularly
with symptoms
of burning and heat, Kat.uka
is combined with
equal parts Pat.
ola, ´Sata¯varı¯, Triphala and Gud.u¯cı¯
(Sharma 2002). Kat.uka
is also important in typically
kaphaja
conditions such as cough and
bronchitis, in
combination with herbs such as Bibhı¯taka, Va¯saka,
and Yas.t.
imadhu, and usually with dı¯panapa¯cana
remedies such as Trikat.u
to offset its cooling energy.
In the treatment of oedema Kat.uka
is mentioned in
formulation with botanicals such as Harı¯takı¯,
Devada¯ru, and Pippalı¯. More recently, Kat.uka
has
been used by Western herbalists as an potent
immunostimulant, in combination with herbs
such as
Purple Coneflower (Echinacea angustifolia) and
Bhu¯nimba, in the treatment of chronic viral infection
and immunodeficiency.
Dosage:
● Cu¯rn.
a: dried rhizome, 2–3 g b.i.d.–t.i.d.
● Tincture: dried rhizome, 1:4, 60% alcohol,
1–3 mL
REFERENCES
Baruah CC, Gupta PP, Nath A et al 1998
Anti-allergic and antianaphylactic
activity of picroliv–a standardised iridoid
glycoside
fraction of Picrorhiza kurroa.
Pharmacological Research
38(6):487–492
Chander R, Kapoor NK, Dhawan BN 1992 Picroliv,
picroside-I and
kutkoside from Picrorhiza kurrooa are
scavengers of superoxide
anions. Biochemical Pharmacology
44(1):180–183
232 PART 2: A¯ yurvedic materia medica
Chander R, Singh K, Visen PK et al 1998 Picroliv prevents
oxidation
in serum lipoprotein lipids of Mastomys
coucha infected with
Plasmodium berghei. Indian Journal of
Experimental Biology
36(4):371–374
Dorsch W, Stuppner H, Wagner H et al 1991
Anti-asthmatic effects
of Picrorhiza kurroa: androsin prevents
allergen- and PAFinduced
bronchial obstruction in guinea pigs.
International
Archives Of Allergy And Applied Immunology
95(2–3):128–133
Dwivedi Y, Rastogi R, Garg NK, Dhawan BN 1992
Effects of picroliv,
the active principle of Picrorhiza kurroa, on
biochemical
changes in rat liver poisoned by Amanita
phalloides. Zhongguo
Yao Li Xue Bao 13(3):197–200
Duke JA 2002 Handbook of medicinal herbs, 2nd
edn. CRC Press,
Boca Raton, p 568
Engels F, Renirie BF, Hart BA et al 1992
Effects of apocynin, a drug
isolated from the roots of Picrorhiza kurroa,
on arachidonic
acid metabolism. FEBS Letters 305(3):254–256
Gaddipati JP, Mani H, Banaudha KK et al 1999
Picroliv modulates
the expression of insulin-like growth factor
(IGF)-I, IGF-II and
IGF-I receptor during hypoxia in rats.
Cellular and Molecular
Life Sciences 56(3–4):348–355
Jeena KJ, Joy KL, Kuttan R 1999 Effect of
Emblica officinalis,
Phyllanthus amarus and Picrorrhiza kurroa on
N-nitrosodiethylamine
induced hepatocarcinogenesis. Cancer Letters
136(1):11–16
Jia Q, Hong MF, Minter D 1999 Pikuroside: a
novel iridoid from
Picrorhiza kurroa. Journal of Natural
Products 62(6):901–903
Joy KL, Kuttan R 1999 Anti-diabetic activity
of Picrorrhiza kurroa
extract. Journal of Ethnopharmacology
67(2):143–8
Joy KL, Rajeshkumar
NV, Kuttan G, Kuttan R 2000
Effect of
Picrorrhiza kurroa extract on transplanted
tumors and chemical
carcinogenesis in mice. Journal of
Ethnopharmacology
71(1–2):261–266
Kapoor LD 1990 CRC handbook of Ayurvedic
medicinal plants. CRC
Press, Boca
Raton, p 263
Kirtikar KR, Basu BD 1935 Indian medicinal
plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1825–1826
Li JX, Li P, Tezuka Y, Namba T, Kadota S 1998
Three phenylethanoid
glycosides and an iridoid glycoside from
Picrorhiza scrophulariiflora.
Phytochemistry 48(3):537–542
Mehrotra R, Rawat S, Kulshreshtha DK 1990 In
vitro studies on the
effect of certain natural products against
hepatitis B virus.
Indian Journal of Medical Research 92:133–8
Mills S, Bone K 2000 Principles and practice
of phytotherapy.
Churchill Livingstone, London, p 154
Mittal N, Gupta N, Saksena S 1998 Protective
effect of Picroliv from
Picrorhiza kurroa against Leishmania donovani
infections in
Mesocricetus auratus. Life Sciences
63(20):1823–1834
MOPE 2001 Nepal’s State of the Environment.
Ministry of
Population and Environment, Kathmandu
p annex 1–2.
Available:
http://www.mope.gov.np/environment/state2001.php
Nadkarni KM 1954 The Indian materia medica,
with Ayurvedic,
Unani and home remedies, revised and enlarged
by A.K.
Nadkarni. Popular Prakashan PVP, Bombay
Puri A, Saxena RP, Sumati et al 1992
Immunostimulant activity of
Picroliv, the iridoid glycoside fraction of
Picrorhiza kurroa, and
its protective action against Leishmania
donovani infection in
hamsters. Planta Medica 58(6):528–532
Rajeshkumar NV, Kuttan R 2000 Inhibition of
N-nitrosodiethylamine-
induced hepatocarcinogenesis by Picroliv.
Journal of
Experimental and Clinical Cancer Research
19(4):459–465
Rajeshkumar NV, Kuttan R 2001 Protective effect of
Picroliv, the
active constituent of Picrorhiza kurroa,
against chemical
carcinogenesis in mice. Teratogenesis,
Carcinogenesis, and
Mutagenesis 21(4):303–313
Rastogi R, Srivastava AK,
Rastogi AK 2001 Long term effect of aflatoxin
B(1) on lipid peroxidation in rat liver and
kidney: effect of
picroliv and silymarin. Phytotherapy Research
15(4):307–310
Santra A, Das S, Maity A et al 1998
Prevention of carbon tetrachloride-
induced hepatic injury in mice by Picrorhiza
kurrooa.
Indian Journal of Gastroenterology 17(1):6–9
Saraswat B, Visen PK, Patnaik GK, Dhawan BN
1997 Protective
effect of picroliv, active constituent of
Picrorhiza kurrooa,
against oxytetracycline induced hepatic
damage. Indian Journal
of Experimental Biology 35(12):1302–1305
Saraswat B, Visen PK, Patnaik GK, Dhawan BN
1999 Ex vivo and in
vivo investigations of picroliv from
Picrorhiza kurroa in an alcohol
intoxication model in rats. Journal of
Ethnopharmacology
66(3):263–269
Senthil Kumar SH, Anandan R, Devaki T,
Santhosh Kumar M 2001
Cardioprotective effects of Picrorrhiza
kurroa against isoproterenol-
induced myocardial stress in rats.
Fitoterapia
72(4):402–405
Sharma ML, Rao CS, Duda PL 1994
Immunostimulatory activity of
Picrorhiza kurroa leaf extract. Journal of
Ethnopharmacology
41(3):185–192
Sharma PV 2002 Cakradatta. Sanskrit text with
English translation.
Chaukhamba, Varanasi, p 12, 65, 114, 234, 347
Singh AK, Mani H, Seth P et al 2000 Picroliv
preconditioning protects
the rat liver against ischemia-reperfusion
injury. European
Journal of Pharmacology 395(3):229–239
Singh V, Visen PK, Patnaik GK 1992 Effect of
picroliv on low density
lipoprotein receptor binding of rat
hepatocytes in hepatic damage
induced by paracetamol. Indian Journal of
Biochemistry
and Biophysics. 29(5):428–432
Smit HF, van den Berg AJ, Kroes BH 2000
Inhibition of T-lymphocyte
proliferation by cucurbitacins from
Picrorhiza scrophulariaeflora.
Journal of Natural Products 63(9):1300–1302
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of
Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 182
Stuppner H, Wagner H 1989 New cucurbitacin
glycosides from
Picrorhiza kurrooa. Planta Medica
55(6):559–563
Vaidya AB, Antarkar DS, Doshi JC et al 1996
Picrorhiza kurroa
(Kutaki) Royle ex Benth as a hepatoprotective
agent: experimental
and clinical studies. Journal of Postgraduate
Medicine
42(4):105–108
Warrier PK, Nambiar VPK, Ramankutty C (eds)
1995 Indian medicinal
plants: a compendium of 500 species, vol 4.
Orient
Longman, Hyderabad, p 269–272
Ku¯s.ma¯n.d.
a 233
Botany: Ku¯s.ma¯n.d.
a is a large trailing plant with stout
angular stems and stiff hairs. The cordate
leaves are
large, up to 12 cm in diameter, with five to
seven lobes,
mostly glabrous above with stiff hairs below.
The flowers
are yellow, monoecious, the male peduncle
longer
than the female. The fruit is a cylindrical
gourd that
grows up to 45 cm in length and can weigh up
to 35 kg.
It is hairy and is covered in a waxy, chalky
coating that
protects it against pests and gives it an
exceptionally
long shelf-life. Ku¯s.ma¯n.d.
a is found throughout Asia in
tropical regions, cultivated as both a food
and medicine
(Kirtikar & Basu 1935, Warrier et al
1994).
Part used: Unripe, maturing and ripened fruit,
seeds.
Dravygun. a:
● Rasa: madhura
● Vipa¯ka: guru (unripe
fruit), laghu (ripe fruit)
● Vı¯rya: ´sita, ru¯ks.
a (unripe fruit); ripe fruit has an
almost neutral vı ¯rya
● Karma: unripe fruit is bhedana, jvaraghna,
raktaprasa¯dana, ´son. itastha¯pana,
da¯hapra´samana,
vajı ¯karan. a, balya, va¯tapittahara; maturing fruit is
kaphakopa; mature fruit and seed is dı ¯pana,
mu¯travirecana, medhya, tridos.aghna (Dash 1991,
Srikanthamurthy 2001, Warrier et al 1994).
Constituents: Researchers have isolated a number
of triterpene glycosides from Ku¯s.ma¯n.d.
a, including
alnusenol and multiflorenol, as well as a
flavonoid
C-glycoside, a benzyl glycoside, and -sitosterol.
Other constituents include proteins, sugars
and fats,
as well as a cucumisin-like serine protease
(Uchikoba
et al 1998, Yoganarasimhan 2000, Yoshizumi et
al
1998).
Medical research:
● In
vivo: anti-ulcerogenic (Grover et al
2001); antiallergenic
(Grover et al 2001, Kumar & Ramu 2002,
Yoshizumi et al 1998); nootropic (Kumar &
Nirmala
2003); anti-withdrawal (Grover et al 2000).
Toxicity: Chronic toxicity studies carried
out for
3 months in experimental animals revealed no
deleterious
effect of fresh juice of B. hispida on various
haematological and biochemical parameters
(Grover
et al 2001).
Indications: Dyspepsia,
colic, intestinal parasites, fever,
dry cough, purulent bronchitis, asthma,
consumption,
wasting, oedema, thirst, burning sensations,
haemorrhage,
urinary calculi, cystitis, leucorrhoea,
epilepsy,
psychosis.
Contraindications: Diarrhoea (Bensky & Gamble
1993).
Medicinal uses: Ku¯s.ma¯n.d.
a is both a medicinal plant
and a vegetable, consumed widely throughout
Asia. In
India Ku¯s.ma¯n.d.
a is highly valued as a nutritive food,
used during convalescence in wasting
diseases,
and prepared as a confection in the treatment
in ulceration
of the lungs and intestines. The fresh fruit
of the
juice is used in haemoptysis and internal
bleeding
(Nadkarni 1954). The Cakradatta
recommends a
lehya
called Va¯sa¯khan.
daku¯s.ma¯n.d.
aka, prepared
from Ku¯s.ma¯n.d.
a pulp, Va¯saka and dı¯panapa¯cana
dravyas
in the treatment of internal
haemorrhaging,
chest wounds, cough, dyspnoea, consumption,
angina
and back pain (Sharma 2002). In Chinese
medicine
the seeds are similarly used in lung
conditions with
a yellowish sputum, as well as in yellowish
mucosal
discharges of the bowels and uterus (Bensky
& Gamble
1993). Ku¯s.ma¯n.d.
a is also an important remedy in the
treatment of unma¯da
(‘psychosis’) and apasma¯ra
Ku¯s.ma¯n.d.
a
BOTANICAL NAMES: Benincasa hispida, B. cerifera, Cucurbitaceae
OTHER NAMES: Petha, Kondha, Kudimah (H); Sambal pushani, Pushanikkai
(T);
Wax Gourd, Winter Melon (E); Dong gua (C)
234 PART 2: A¯ yurvedic materia medica
(‘epilepsy’). The Cakradatta
recommends the fresh
juices of Ku¯s.ma¯n.d.
a, Bra¯hmı¯, Vaca¯, ´San.khapus.pı¯ and
Kus.
t.
ha, taken with honey, in the treatment of unma¯da
(Sharma 2002). Similarly, the Bha¯vapraka¯´sa
recommends
that 18 parts the fresh juice of Ku¯s.ma¯n.d.
a be
decocted in one part ghr.
ta, with a paste of
Yas.t.
imadhu, down to one part ghr.
ta, in the treatment
of apasma¯ra (Srikanthamurthy 2000). In the treatment
of difficult cases of intestinal colic the
Bha¯vapraka¯´sa
recommends that the freshly dried
Ku¯s.ma¯n.d.
a fruit be heated until red hot over a mild
fire,
reduced to a powder, and taken with a little ´Su¯n.t.
hı¯
(Srikanthamurthy 2000). In the treatment of
cystitis
the Cakradatta recommends the fresh juice of
Ku¯s.ma¯n.d.
a with Yavaks.a¯ra and sugar (Sharma 2002).
Much like pumpkin seeds, the seeds of Ku¯s.ma¯n.d.
a are
consumed in the treatment of intestinal parasites.
Dosage:
● Cu¯rn.
a: dried pulp and/or seed, 2–10 g
b.i.d.–t.i.d.
● Svarasa: 30–120 mL b.i.d.–t.i.d.
REFERENCES
Bensky D, Gamble A 1993 Chinese herbal
medicine materia medica,
revised edn. Eastland Press, Seattle, p 135
Dash B 1991 Materia medica of Ayurveda. B
Jain Publishers, New
Delhi, p 317–318
Grover JK, Rathi SS, Vats V 2000 Preliminary
study of fresh juice of
Benincasa hispida on morphine addiction in
mice. Fitoterapia
71(6):707–709
Grover JK, Adiga G, Vats V, Rathi SS 2001
Extracts of Benincasa
hispida prevent development of experimental
ulcers. Journal of
Ethnopharmacology 78(2–3):159–164
Kapoor LD 1990 CRC Handbook of Ayurvedic
medicinal plants. CRC
Press, Boca Raton
Kirtikar KR, Basu BD 1935 Indian medicinal
plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1127
Kumar A, Nirmala V 2003 Nootropic activity of
methanol extract of
Benincasa hispida fruit. Indian Journal of
Pharmacy
35:194–201
Kumar A, Ramu P 2002 Effect of methanolic
extract of Benincasa
hispida against histamine and acetylcholine
induced bronchospasm
in guinea pigs. Indian Journal of
Pharmacology
34:365–366
Nadkarni KM 1954 The Indian materia medica,
with Ayurvedic,
Unani and home remedies, revised and enlarged
by A.K.
Nadkarni. Popular Prakashan PVP, Bombay, p
186
Sharma PV 2002 Cakradatta: Sanskrit text with
English translation.
Chaukhamba, Varanasi, p 130, 184
Srikanthamurthy KR 2000 Bha¯vapraka¯´sa of
Bha¯vami´sra, vol 2.
Krishnadas Academy, Varanasi, p 313, 426
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of
Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 388
Uchikoba T, Yonezawa H, Kaneda M 1998
Cucumisin like protease
from the sarcocarp of Benincasa hispida var.
Ryukyu.
Phytochemistry 49(8):2215–2219
Warrier PK, Nambiar VPK, Ramankutty C (eds)
1994 Indian medicinal
plants: a compendium of 500 species, vol 1.
Orient
Longman, Hyderabad, p 261
Yoganarasimhan SN 2000 Medicinal plants of
India, vol 2: Tamil
Nadu. Self-published, Bangalore, p 75
Yoshizumi S, Murakami T, Kadoya M et al 1998
Medicinal
foodstuffs. XI. Histamine release inhibitors
from wax gourd,
the fruits of Benincasa hispida Cogn.
Yakugaku Zasshi
118(5):188–192
Kus.
t.
ha, ‘disease’ 235
Botany: Kus.
t.
ha is a robust erect perennial herb with
a stout stem attaining a height of up to 2 m,
and roots
up to 60 cm long that have a distinctive,
characteristic
odour. The leaves are membranous and
irregularly
toothed, the basal leaves quite large, up to
1.2 m in
length, triangularly shaped with a winged
stalk, the
terminal lobe up to 30 cm across. The upper
leaves
arise from the stem and are smaller, with two
clasping
lobes at the base. The bluish-purple flowers
are borne
in axillary and terminal clusters, giving
rise to compressed
achenes. Kus.
t.
ha is native to the Himalayas,
from Kashmir to Sikkim, northwards into Tibet
and
eastwards into Yunnan province in China,
between
elevations of 2500 and 4000 m. Kus.
t.
ha is currently
threatened with extinction due to unregulated
harvesting
and is listed in CITES Appendix I (Kirtikar
&
Basu 1935, MOPE 2001, Warrier et al 1996).
Part used: Root.
Dravygun. a:
● Rasa: tikta, kat.u, madhura
● Vipa¯ka: madhura
● Vı¯rya: us.n.
a
● Karma: dı ¯panapa¯cana, jvaraghna, chedana, ka¯sahara,
sva¯sahara, mu¯travirecana, raktaprasa¯dana,
kus.t.
haghna, vedana¯stha¯pana, stanyajanana,
vajı ¯karan. a, rasa¯yana, va¯takaphahara (Nadkarni
1954, Srikanthamurthy 2001, Warrier et al
1996).
Constituents: Kus.t.ha contains an essential oil used
in perfumery called costus oil, comprising
upwards of
1.5% of the dried plant, that has a woody,
musty, lingering
smell. Costus oil is composed mostly of
sesquiterpene lactones, including
dihydrocostus lactone
(15%) and costos lactone (10%), other
constituents
including aplotaxene (20%), -costen (6%),
-costen (6%), and costic acid (14%), and also smaller
amounts of camphene, phellandrene,
caryophyllene
and selinene. Non-volatile constituents
include amino
acid-sesquiterpene adducts saussureamines
A–E, a
lignan glycoside, the alkaloid saussurine, a
bitter principle,
a resin, tannin, fixed oil, inulin and sugar
(De
Kraker et al 2001, Kapoor 1990, Lawless 1995,
Yoshikawa et al 1993).
Medical research:
● In
vitro: anti-inflammatory (Cho et al
2000,
Gokhale et al 2002, Matsuda et al 2003), anti-
HBsAg (Chen et al 1995), antitumour (Jeong et
al
2002, Ko et al 2004, 2005).
● In
vivo: anti-ulcer (Yoshikawa et al 1993)
● Human
trials: in healthy volunteers a decoction
of Saussurea lappa was found to accelerate gastric
emptying and increase endogenous motilin
release,
an amino acid peptide that regulates upper GI
motility (Chen et al 1994).
Toxicity: Costus oil isolated from Saussurea lappa is
associated with several cases of allergic
contact dermatitis
(Cheminat et al 1981).
Indications: Dyspepsia, biliousness,
gastrointestinal
spasm, diarrhoea, dysentery, fever,
bronchitis,
asthma, skin diseases, dysmenorrhoea, muscle
spasm,
gout, autotoxicity.
Contraindications: pittakopa. Bensky & Gamble
(1993) stated that Kus.
t.
ha is contraindicated in yin
deficiency and dryness.
Medicinal uses: The name Kus.
t.
ha refers to an
ancient Vedic plant god mentioned in the Atharva
veda
as a remedy for takman, the archetypal disease
of excess or jvara
(fever). In ancient India Kus.
t.
ha
was considered to be a divine plant derived
from
Kus.
t.
ha, ‘disease’
BOTANICAL NAMES: Saussurea lappa, Aucklandia lappa, Asteraceae
OTHER NAMES: Kuth, Kur (H); Kostam, Goshtam (T); Costus (E); Mu xiang
(C)
236 PART 2: A¯ yurvedic materia medica
heavenly sources, growing high in the Himalayas,
considered to be the brother of the divine Soma
(Zysk
1998). From its Sanskrit name it could be
inferred that
Kus.
t.
ha is a specific for skin disease (i.e. kus.t.
ha),
and indeed it is used as such, primarily as raktaprasa
¯dana, or alterative. Although it is not
considered
among the most important plants in the
treatment of skin disease it is used in a
variety of skin
conditions, from leprosy, ulcers and ringworm
to leucoderma
and simple pruritis. More importantly,
Kus.
t.
ha is a rasa¯yana for va¯ta, helping to normalise
and strengthen digestion, cleanse the body of
toxic
accumulations, enhance fertility and reduce
pain. As
a bitter tasting herb Kus.
t.
ha acts on the liver and gall
bladder, stimulating bile synthesis and
excretion, and
as an aromatic, acts as a carminative to ease
cramping
and intestinal colic. Generally speaking, Kus.
t.
ha is an
important remedy in any kind of spasm or
pain, be it
smooth or skeletal muscle, primarily due to
its ability
to normalise va¯ta. In the treatment of cramping
and spasm of the abdomen or musculature the
Cakradatta
recommends a topical preparation
called
Kus.
t.
hadi
taila, comprising taila
and vinegar, mixed
with powders of Kus.
t.
ha and saindhava, and massaged
into the affected tissues (Sharma 2002). Mixed
with equal parts powders of Hin.gu, Trikat.u,
Yavaks.a¯ra
and saindhava, Kus.
t.
ha is mixed with
Ma¯tulun.ga
juice and taken internally to
alleviate
abdominal pain (Sharma 2002). Similarly, Kus.
t.
ha is
used in Chinese medicine mixed with Bai zhu
(Atractylodes macrocephala) for epigastric pain and
bloating (Bensky & Gamble 1993). In the
treatment of
diarrhoea and dysentery Kus.
t.
ha can be taken along
with Kut.aja, Harı¯takı¯, ´Su¯n.t.
hı¯, Mustaka, and
Da¯ruharidra¯. In the treatment of u¯rusthambha
(paraplegia), the Cakradatta
recommends Kus.
t.
ha¯dya
taila, composed of Kus.
t.
ha, ´Srives.t.
aka
resin,
Udı¯cya, Sarala wood, Devada¯ru, Na¯gake´sara,
Ajagandha¯
and A´svagandha¯
decocted in mustard
oil, taken internally with honey (Sharma
2002). In
the treatment of va¯ttika
headache the ´Sa¯ran
. gadhara
sam.
hita¯ recommends a paste of Kus.
t.
ha
cu¯rn.
a
prepared with rice water and castor oil,
applied topically
(Srikanthamurthy 1984). In the treatment of
toothache, gum swelling and bleeding, Kus.
t.
ha is
mixed with equal parts Da¯rvı¯, Mañjis.t.
ha¯, Pa¯t.ha¯,
Kat.uka, Haridra¯, Tejanı¯, Mustaka and Lodhra,
and applied to the gums (Srikanthamurthy
1984).
In the treatment of va¯ttika
udara roga in which
apa¯na
va¯yu moves upwards, characterised by
abdominal bloating and pain, and accompanied
by
joint pain, bodyache and lethargy, the Bha¯vapraka¯´sa
recommends Kus.
t.
hadi
cu¯rn.
a, composed of equal
parts Kus.
t.
ha along with dı¯panapa¯cana
remedies
such as Hin.gu, Cavya, Citraka and ´Su¯n.t.
hı¯
(Srikanthamurthy 2000). In the treatment of va¯ttika
anorexia, Kus.
t.
ha
cu¯rn.
a is taken with equal parts
Sauvarcala
(Sanchal salt), Jı¯raka, Marica, Vid.
a
(black salt) and sugar, with taila
and honey as an
anupa¯na
(Sharma 2002). In the treatment of
unma¯da
(‘psychosis’), the Cakradatta
recommends
a combination of equal parts Kus.
t.
ha with Bra¯hmı¯,
Ku¯s.ma¯n.d.
a, Vaca¯ and ´San.khapus.pı¯, taken with
honey (Sharma 2002). To keep children healthy
and
strong, the Cakradatta
recommends a lehya
prepared
from equal parts Kus.
t.
ha, Vaca¯, Bra¯hmı¯, and
Svarn.
a (purified gold), prepared with honey and
ghr.
ta, (Sharma 2002). As a refreshing
mouth rinse,
the Cakradatta recommends Kus.
t.
hadi
kavala,
comprised of equal parts infusion of Kus.
t.
ha,
Ela¯valuka, Ela¯, Mustaka, Dha¯nyaka and honey
(Sharma 2002). In the treatment of asthma, a
tincture
of Kus.
t.
ha is stated to be particularly effective to
relieve bronchial spasm (Kirtikar & Basu
1935,
Nadkarni 1954).
Dosage:
● Cu¯rn.
a: freshly dried root, 3–5 g b.i.d.–t.i.d.
● Pha¯n.t.
a: freshly crushed root, 1:4, 30–60 mL
b.i.d.–t.i.d.
● Tincture: freshly dried root, 1:4, 50% alcohol, 1–5
mL
REFERENCES
Bensky D, Gamble A 1993 Chinese herbal
medicine materia medica,
revised edn. Eastland Press, Seattle, p
237–238
Cheminat A, Stampf JL, Benezra C et al 1981
Allergic contact dermatitis
to costus: removal of haptens with polymers.
Acta
Dermato-Venereologica 61(6):525–529
Chen HC, Chou CK, Lee SD et al 1995 Active
compounds from
Saussurea lappa Clarks that suppress
hepatitis B virus surface
antigen gene expression in human hepatoma
cells. Antiviral
Research 27(1–2):99–109
Chen SF, Li YQ, He FY 1994 Effect of
Saussurea lappa on gastric
functions. Zhongguo Zhong Xi Yi Jie He Za Zhi
14(7):406–408
Cho JY, Baik KU, Jung JH, Park MH 2000 In
vitro anti-inflammatory
effects of cynaropicrin, a sesquiterpene
lactone, from
Saussurea lappa. European Journal of
Pharmacology
398(3):399–407
Kus.
t.
ha, ‘disease’ 237
De Kraker JW, Franssen MC, De Groot A et al
2001 Germacrenes
from fresh costus roots. Phytochemistry 58(3):481–487
Gokhale AB, Damre AS, Kulkami KR, Saraf MN
2002 Preliminary
evaluation of anti-inflammatory and
anti-arthritic activity of
S. lappa, A. speciosa and A. aspera.
Phytomedicine
9(5):433–437
Jeong SJ, Itokawa T, Shibuya M et al 2002
Costunolide, a sesquiterpene
lactone from Saussurea lappa, inhibits the
VEGFR
KDR/Flk–1 signaling pathway. Cancer Letters
187(1–2):129–133
Kapoor LD 1990 CRC handbook of Ayurvedic
medicinal plants.
CRC Press, Boca Raton, p 300
Kirtikar KR, Basu BD 1935 Indian medicinal
plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1420–1422
Ko SG, Koh SH, Jun CY et al 2004 Induction of
apoptosis by
Saussurea lappa and Pharbitis nil on AGS
gastric cancer cells.
Biological and Pharmaceutical Bulletin
27(10):1604–1610
Ko SG, Kim HP, Jin DH et al 2005 Saussurea
lappa induces G2-
growth arrest and apoptosis in AGS gastric
cancer cells. Cancer
Letters 220(1):11–19
Lawless J 1995 The illustrated encyclopedia
of essential oils.
Element, Rockport MA, p 219
Matsuda H, Toguchida I, Ninomiya K et al 2003
Effects of
sesquiterpenes and amino acid-sesquiterpene
conjugates from
the roots of Saussurea lappa on inducible
nitric oxide synthase
and heat shock protein in
lipopolysaccharide-activated
macrophages. Bioorganic and Medicinal
Chemistry
11(5):709–715
MOPE 2001 Nepal’s State of the Environment.
Ministry of
Population and Environment, Kathmandu p annex
1–2.
Available:
http://www.mope.gov.np/environment/state2001.php
Nadkarni KM 1954 The Indian materia medica,
with Ayurvedic,
Unani and home remedies, revised and enlarged
by A.K.
Nadkarni. Popular Prakashan PVP, Bombay, p
1112
Sharma PV 2002 Cakradatta. Sanskrit text with
English translation.
Chaukhamba, Varanasi, p 107, 165, 184, 245,
267, 595,
656
Srikanthamurthy KR 1984 ´Sa¯ran . gadhara
sam. hita¯: a treatise on
Ayurveda. Chaukhamba Orientalia, Varanasi, p
235, 242
Srikanthamurthy KR 2000 Bha¯vapraka¯´sa of
Bhavami´sra, vol. 2.
Krishnadas Academy, Varanasi, p 519
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of
Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 186,
Warrier PK, Nambiar VPK, Ramankutty C (eds)
1996 Indian
medicinal plants: a compendium of 500
species, vol 5. Orient
Longman, Hyderabad, p 80–83
Yoshikawa M, Hatakeyama S, Inoue Y, Yamahara
J 1993
Saussureamines A, B, C, D, and E, new anti-ulcer
principles
from Chinese Saussureae Radix. Chemical and
Pharmaceutical
Bulletin (Tokyo) 41(1):214–216
Zysk KG 1998 Asceticism and healing in
ancient India: medicine in
the Buddhist monastery. Motilal Banarsidass,
Delhi, p 19
238 PART 2: A¯ yurvedic materia medica
Botany: Kut.aja
is a shrub or small tree with pale
coloured bark that exudes a whitish latex
when cut.
The leaves are simple, broadly ovate to
elliptic,
glabrous or pubescent, with 10–14 pairs of
conspicuous
nerves, oppositely arranged on short
petioles. The
flowers are white, without odour, borne in
terminal
flat-topped cymes, giving rise to long narrow
fruits
that are tipped with a crown of brown hairs. Kut.aja
is
found throughout India and Southeast Asia, in
deciduous
forests up to 900 m (Kirtikar & Basu
1935,
Warrier et al 1995).
Part used: Bark (Kut.aja), seeds (Indrayava).
Dravygun. a:
● Rasa: ka´sa¯ya, tikta
● Vipa¯ka: laghu
● Vı¯rya: ´sita
● Karma: dı ¯pana, chardinigrahan. a, purı ¯s.asangrahan. ı ¯ya,
kr . mighna, jvaraghna, ka¯sahara,
sva¯sahara,
´son. itastha¯pana, kus.t.
haghna, kaphahara (Dash 1991,
Srikanthamurthy 2001, Warrier et al 1995).
Constituents: Researchers
have isolated only a few
classes of constituents from Kut.aja, mostly
alkaloids, as well as steroidal alkaloids and
steroids.
Among the alkaloidal constituents are
conessine,
conessimine, kurchine, conamine, conimine,
conessidine,
conarrhimine, holarrhimine, holarrhine and
kurchicine. Steroidal alkaloids include
antidysentericine
and regholarrhenines A–F. Recently isolated
steroidal compounds include pubadysone,
puboestrene
and pubamide. Other constituents include
-sitosterol, a triterpene alcohol, lupeol, gum, lettoresinols
A and B, and tannins (Kapoor 1990, Kumar
and Ali 2000, Siddiqui et al 2001, Williamson
2002,
Yoganarasimhan 2000).
Medical research:
● In
vitro: antibacterial (Aqil et al 2005,
Chakraborty
& Brantner 1999, Kavitha et al 2004, Rani
& Khullar
2004, Voravuthikunchai et al 2004).
● In
vivo: anti-amoebic, antidysentery (Duke
2002,
Williamson 2002); antidiarrhoeal (Kavitha et
al
2004); immunomodulant (Atal et al 1986).
Toxicity: No data found.
Indications: Dyspepsia,
diarrhoea, dysentery, amoebic
dysentery, intestinal parasites,
haemorrhoids, fever,
malaria, asthma, pneumonia, jaundice,
hepatosplenomegaly,
internal haemorrhaging, menorrhagia,
rheumatism, skin diseases.
Contraindications: Constipation, va¯takopa.
Medicinal uses: Kut.aja is an exceptionally important
and useful remedy in diarrhoea and dysentery,
and for this purpose the bark is preferred,
which in
addition to containing antimicrobial
alkaloids also
contains tannins that help to astringe the
gut mucosa.
Among the best remedies to treat infectious
diarrhoea
is Kut.aja aris.t.
a, a fermented preparation mentioned
in the Bhais.ajyaratna¯valı¯, taken in dosages of
12–24 mL in the treatment of dysentery,
bloody
diarrhoea, malabsorptive syndromes, and fever
(India 1978). In the treatment of diarrhoea
the
Cakradatta
recommends a cu¯rn.
a composed of equal
parts Trikat.u, Indrayava, Nimba, Bhu¯nimba,
Bhr.n
. gara¯ja, Citraka, Kat.uka, Pa¯t.ha¯, Da¯ruharidra¯
and purified Ativis.a¯, the total of which is mixed with
an equal quantity of Kut.aja, taken in doses of 3–5 g
with rice water or honey (Sharma 2002).
Simpler formulations
mentioned by the Cakradatta
include a
decoction of Indrayava, Kut.aja and Mustaka,
30–120 mL, taken with sugar and honey, or Kut.aja
and Da¯d.ima pericarp (Punica granatum) prepared as a
thick extract by decoction, taken in
teaspoonful doses
Kut.
aja, ‘mountain born’
BOTANICAL NAMES: Holarrhena antidysenterica, H. pubescens, Apocynaceae
OTHER NAMES: Indrayava, ‘Indra’s seeds’ (S); Kurchi, Kuda (H); Kutashappalai,
Veppalai (T); Kurchi tree, Conessi tree (E)
Kut.aja, ‘mountain born’ 239
with buttermilk (Sharma 2002). In the
treatment
of haemorrhoids the Cakradatta
recommends
Kut.ajaleha, Kut.aja¯rasakriya¯, and Kut.aja¯dya
ghr.
ta, the latter of which is prepared
by medicating
ghr.
ta with equal parts Kut.aja, Na¯gake´sara, Nı¯lotpala,
Lodhra, and Dha¯taki, taken in doses of 3–12 g
(Sharma 2002). Beyond its ability to check
the secretions
of the digestive tract, Kut.aja
is also widely used
as an antihaemorrhagic. In the treatment of
menorrhagia
Kut.aja
can be combined with herbs such as
Arjuna, Bilva and Nı¯lotpala, or non-Indian herbs
such as Shepherd’s Purse (Capsella bursa-pastoris) and
Cranesbill (Geranium maculatum). For pthisis and
tuberculosis Kut.aja
can be used to check bleeding, in
combination with herbs such as Va¯saka, A¯malakı¯,
Pus.karamu¯la
and Arjuna. Combined with equal
parts A¯malakı¯, Arjuna and Nimba, Kut.aja is taken
as a powder with honey for the paittika
variants of
polyuria, indicated by polyuria with symptoms
of
burning sensations, the urine coloured deep
yellow to
red, with a pungent odour (Sharma 2002).
Dosage:
● Cu¯rn.
a: bark and/or seed, 3–8 g b.i.d.–t.i.d.
● Tincture: bark, 1:3, 70% alcohol, 2–5 mL
b.i.d.–t.i.d.
REFERENCES
Aqil F, Khan MS, Owais M, Ahmad I 2005 Effect
of certain bioactive
plant extracts on clinical isolates of
beta-lactamase producing
methicillin resistant Staphylococcus aureus.
Journal of Basic
Microbiology 45(2):106–114
Atal CK, Sharma ML, Kaul A, Khajuria A 1986
Immunomodulating
agents of plant origin. I: Preliminary
screening. Journal of
Ethnopharmacology 18(2):133–141
Chakraborty A, Brantner AH 1999 Antibacterial
steroid alkaloids
from the stem bark of Holarrhena pubescens.
Journal of
Ethnopharmacology 68(1–3):339–344
Dash B 1991 Materia medica of Ayurveda. B.
Jain Publishers, New
Delhi, p 49
Duke JA 2002 Handbook of medicinal herbs, 2nd
edn. CRC Press,
Boca Raton, p 219
India, Department of Health 1978 The Ayurvedic
formulary of
India, Part 1. Controller of Publications, Delhi, p 7
Kapoor LD 1990 CRC handbook of Ayurvedic
medicinal plants.
CRC Press, Boca Raton, p 205–206
Kavitha D, Shilpa PN, Devaraj SN 2004
Antibacterial and antidiarrhoeal
effects of alkaloids of Holarrhena antidysenterica
WALL. Indian Journal of Experimental Biology
42(6):589–594
Kirtikar KR, Basu BD 1935 Indian medicinal
plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1570
Kumar A, Ali M 2000 A new steroidal alkaloid
from the seeds of
Holarrhena antidysenterica. Fitoterapia
71(2):101–104
Nadkarni KM 1954 The Indian materia medica,
with Ayurvedic,
Unani and home remedies, revised and enlarged
by A.K.
Nadkarni. Popular Prakashan PVP, Bombay
Rani P, Khullar N 2004 Antimicrobial
evaluation of some medicinal
plants for their anti-enteric potential
against multi-drug
resistant Salmonella typhi. Phytotherapy
Research
18(8):670–673
Sharma PV 2002 Cakradatta: Sanskrit text with
English translation.
Chaukhamba, Varanasi, p 47, 53, 90, 326
Siddiqui BS, Usmani SB, Ali ST et al 2001 Further constituents
from
the bark of Holarrhena pubescens.
Phytochemistry
58(8):1199–1204
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of
Bha¯vami´sra, vol 1.
Krishnadas Academy,
Varanasi, p
183, 245
Voravuthikunchai S, Lortheeranuwat A, Jeeju W
et al 2004
Effective medicinal plants against
enterohaemorrhagic
Escherichia coli O157:H7. Journal of
Ethnopharmacology
94(1):49–54
Warrier PK, Nambiar VPK, Ramankutty C (eds)
1995 Indian
medicinal plants: a compendium of 500
species, vol 3. Orient
Longman, Hyderabad, p 156
Williamson EM (ed) 2002 Major herbs of
Ayurveda. Churchill
Livingstone, London, p 173
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2:
Tamil
Nadu. Self-published, Bangalore, p 272
Om Tat Sat
(Continued...)
(My humble
salutations to Sreeman Todd
Caldecott, Elsevier’s
Health Sciences and others other eminent medical scholars and doctors for the collection)
0 comments:
Post a Comment